Sulzermedica takes over German cardio business
This article was originally published in Clinica
Executive Summary
Sulzermedica, the medical device business of Swiss engineering company Sulzer, will expand its cardiovascular know-how with the acquisition of German company Osypka and its Florida-based US subsidiary, Oscor Medical. The deal, for an undisclosed amount, will add technology in several cardiovascular areas including pacemaker leads, high-frequency cardiac ablation, catheters and external pacemakers, says Andre Buchel, head of Sulzermedica. Dr Peter Osypka will join Sulzermedica, concentrating on R&D.